Articles tagged "Kidney transplantation"

2018 American Transplant Congress
Change of Bone and Mineral Metabolism in Kidney Donors after Uninephrectomy; Prospective Observational Study
E. Ko,^1,2 H. Cho,^1,3 B. Choi,^1,2 C. Park,^1,2 Y. Kim,^1,2 C. Yang,^1,2 B. Chung.^1,2
¹Transplant Research Center, Seoul St.Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea; ²Division of Nephrology, Department of Internal Medicine, Seoul St.Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea; ³Department of Urology, Seoul St.Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
ackground: The aim of this study is to investigate whether uninephrectomy for kidney donation cause change of bone and mineral metabolism and also investigate factors…
2018 American Transplant Congress
Effects of Health Literacy and Numeracy Literacy on Adherence, Quality of Life and Readiness to Transition in Pediatric Renal Transplant Recipients
M. Kamel,¹ C. McCracken,¹ A. Wilkerson,¹ N. Alexander,¹ J. Gazmararian,² R. George.¹
¹Pediatrics, Emory University & Children's Healthcare of Atlanta, Atlanta, GA; ²Epidemiology, Emory University & Rollins School of Public Health, Atlanta, GA.
Introduction: An adequate level of functional health literacy is essential for transplant recipients and caregivers to comprehend complex information and be adherent to recommendations. Given…
2018 American Transplant Congress
Patient Experience after Kidney Transplant: Factors That Lessen the Burden of Treatment after Kidney Transplant
E. Lorenz,¹ J. Egginton,¹ M. Stegall,¹ R. Heilman,² S. Nair,² M. Mai,³ D. Eton.¹
¹Mayo Clinic, Rochester; ²Mayo Clinic, Scottsdale; ³Mayo Clinic, Jacksonville.
Background: Patients face a daunting regimen of medications, health monitoring and medical appointments following kidney transplant. This workload of healthcare and its impact on patient…
2018 American Transplant Congress
Utilization of Public Health Service Increased Risk Kidneys in Pediatric Renal Transplant Recipients by Era
M. Meyers,¹ J. Shults,¹ B. Laskin,¹ P. Porrett,² M. Levine,² P. Abt,² S. Amaral,^1,2 D. Goldberg.²
¹Children's Hospital of Philadelphia, Philadelphia; ²University of Pennsylvania, Philadelphia.
Purpose: Donors labeled Public Health Service Increased Risk (PHS-IR) continue to rise due to opioid abuse and expanding criteria defining 'increased-risk.' Many PHS-IR donors are…
2018 American Transplant Congress
Analysis of Cost Effectiveness of Treatment for Acute Antibody-Mediated Rejection
C. McDermott, K. Carsky, P. Ferrin, A. Gaines, D. Chernobylsky, M. Killackey, A. Paramesh, R. Zhang, J. Buell.
Tulane University School of Medicine, New Orleans, LA.
Purpose: Because AMR can be a risk factor for graft loss, the expense created by AMR treatment may be subject to scrutiny in patients who…
2018 American Transplant Congress
Two Similar Risk Models Identify Different Patients for Graft Loss: Implications for Clinical Trials in DSA+ Kidney Transplant Recipients
A. Bentall, B. Smith, W. Park, C. Schinstock, M. Stegall.
William J von Liebig Transplant Center, Mayo Clinic, Rochester.
Introduction. Kidney Transplant Recipients (KTx) with donor-specific alloantibody (DSA) at transplantation have increased death-censored graft failure (DCGF) due to chronic antibody mediated rejection (cABMR), but…
2018 American Transplant Congress
Timing of Treatment for Chronic Hepatitis C Infection in Patients with End-Stage Renal Disease Awaiting Transplantation
M. Eckman,¹ E. Woodle,² C. Thakar,¹ F. Paterno,² K. Sherman.¹
¹Medicine, University of Cincinnati, Cincinnati, OH; ²Surgery, University of Cincinnati, Cincinnati, OH.
BackgroundIt is unclear whether patients with chronic hepatitis C virus (HCV) infection and end-stage renal disease (ESRD) should be treated for HCV before transplant or…
2018 American Transplant Congress
High GFR in Kidney Donors is Associated with Increased Risk of Proteinuria and Diabetes
D. Keys, S. Riad, V. Vakil, S. Jackson, D. Berglund, A. Matas.
University of Minnesota, Minneapolis, MN.
Background: Measured glomerular filtration rate (GFR) has been part of the donor evaluation to rule out low GFR donors from taking undue risk for ESRD.…
2018 American Transplant Congress
Time within Therapeutic Range: A Comparison of Three Tacrolimus Formulations in Renal Transplant Recipients
K. Khalil, P. West-Thielke, A. Lichvar, E. Benedetti, S. Patel.
University of Illinois Hospital & Health Sciences System, Chicago, IL.
Purpose: To compare three formulations of tacrolimus (TAC) and assess differences in time within therapeutic range (TTR) and variability in levels.Methods: Renal transplant recipients from…
2018 American Transplant Congress
Pharmacokinetics of Mycophenolic Acid Following Enteric-Coated Mycophenolate Sodium Administration in Chinese Renal Transplant Recipients
W. Peng, C. Tian, Z. Chen, W. Xue, G. Wang, Q. Ye, X. Zhang, M. Gu, M. Zhao, C. Wang, C. Huang, J. Yan, W. Zhang, C. Ding, Y. Fu, S. Ye, X. Hu, R. Tan, M. Li, R. Deng, Y. Ke, W. Wu, M. Fan, J. Chen.
MyERA Study Group, Hangzhou, China.
Background: Mycophenolic acid (MPA), active component of mycophenolate mofetil (MMF) or enteric-coated mycophenolate sodium (EC-MPS), is the most commonly used immunosuppressant in renal transplant recipients…